Pacira Cash from 2010 to 2024

PCRX Stock  USD 17.42  0.13  0.74%   
Pacira BioSciences, Cash yearly trend continues to be fairly stable with very little volatility. Cash will likely drop to about 117.4 M in 2024. Cash is the total amount of money in the form of currency that Pacira BioSciences, has in its possession. This includes all bills, coins, and funds in bank accounts. View All Fundamentals
 
Cash  
First Reported
2008-12-31
Previous Quarter
247.1 M
Current Value
246 M
Quarterly Volatility
92.3 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Pacira BioSciences, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pacira BioSciences,'s main balance sheet or income statement drivers, such as Depreciation And Amortization of 79.4 M, Interest Expense of 15.8 M or Selling General Administrative of 63.1 M, as well as many indicators such as Price To Sales Ratio of 2.19, Dividend Yield of 0.0014 or PTB Ratio of 1.7. Pacira financial statements analysis is a perfect complement when working with Pacira BioSciences, Valuation or Volatility modules.
  
Check out the analysis of Pacira BioSciences, Correlation against competitors.
For more information on how to buy Pacira Stock please use our How to Invest in Pacira BioSciences, guide.

Latest Pacira BioSciences,'s Cash Growth Pattern

Below is the plot of the Cash of Pacira BioSciences, over the last few years. Cash refers to the most liquid asset of Pacira BioSciences,, which is listed under current asset account on Pacira BioSciences, balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Pacira BioSciences, customers. The amounts must be unrestricted with restricted cash listed in a different Pacira BioSciences, account. It is the total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts. Pacira BioSciences,'s Cash historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Pacira BioSciences,'s overall financial position and show how it may be relating to other accounts over time.
Cash10 Years Trend
Slightly volatile
   Cash   
       Timeline  

Pacira Cash Regression Statistics

Arithmetic Mean119,465,325
Geometric Mean76,198,575
Coefficient Of Variation116.11
Mean Deviation78,827,650
Median99,957,000
Standard Deviation138,715,751
Sample Variance19242.1T
Range573.2M
R-Value0.43
Mean Square Error16882.5T
R-Squared0.19
Significance0.11
Slope13,351,811
Total Sum of Squares269388.8T

Pacira Cash History

2024117.4 M
2023153.3 M
2022104.1 M
2021585.6 M
2020100 M
201978.2 M
2018132.5 M

Other Fundumenentals of Pacira BioSciences,

Pacira BioSciences, Cash component correlations

About Pacira BioSciences, Financial Statements

Pacira BioSciences, investors use historical fundamental indicators, such as Pacira BioSciences,'s Cash, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Pacira BioSciences,. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Cash153.3 M117.4 M
Cash And Short Term Investments278.6 M237.8 M
Change In Cash49.2 M51.6 M
Free Cash Flow139.5 M146.5 M
Begin Period Cash Flow104.1 M89.8 M
Other Cashflows From Financing Activities-2.2 M-2.1 M
Other Non Cash Items19.4 M20.4 M
Total Cash From Operating Activities154.6 M162.4 M
Total Cash From Financing Activities-183 M-173.9 M
End Period Cash Flow153.3 M99.9 M
Total Cashflows From Investing Activities-202.7 M-192.5 M
Cash And Cash Equivalents Changes558.5 M586.4 M
Cash Flows Other Operating-5.1 M-4.9 M
Other Cashflows From Investing Activities-381.6 M-362.6 M
Free Cash Flow Yield 0.09  0.09 
Operating Cash Flow Per Share 3.35  3.51 
Free Cash Flow Per Share 3.02  3.17 
Cash Per Share 6.03  8.93 
Capex To Operating Cash Flow 0.10  0.09 
EV To Operating Cash Flow 12.88  23.50 
EV To Free Cash Flow 14.28  15.00 
Price To Operating Cash Flows Ratio 10.08  9.58 
Price To Free Cash Flows Ratio 11.18  11.74 
Cash Ratio 1.57  1.24 
Cash Conversion Cycle 232.31  243.92 
Operating Cash Flow Sales Ratio 0.23  0.24 
Free Cash Flow Operating Cash Flow Ratio 0.90  0.81 
Cash Flow Coverage Ratios 0.30  0.31 
Price Cash Flow Ratio 10.08  9.58 
Cash Flow To Debt Ratio 0.30  0.31 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Pacira Stock Analysis

When running Pacira BioSciences,'s price analysis, check to measure Pacira BioSciences,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pacira BioSciences, is operating at the current time. Most of Pacira BioSciences,'s value examination focuses on studying past and present price action to predict the probability of Pacira BioSciences,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pacira BioSciences,'s price. Additionally, you may evaluate how the addition of Pacira BioSciences, to your portfolios can decrease your overall portfolio volatility.